Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Israel-Rosen who wrote (656)	4/28/1998 8:24:00 AM
From: crysball	Read Replies (1) of 1491

Concur that Cataract Post-Op is the current market for Lotemax, but what will the marketplace look like in a few years, when the cost and time for vision correction surgery [PTK -Sands procedure et al] have dropped significantly, and the Post-Op vision correction market may far exceed the Cataract Pot-Op? David, would you share with us your reasoning on raising your 18 month target for PARS to $15 share? Could you also advise your impressions of Pars Israel?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next